Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-MUC16, ACA125 Vector   (CAT#: GTVCR-WQ245MR)

This product GTVCR-WQ245MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting MUC16. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Mus musculus
RefSeq NM_024690.2
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 94025
UniProt ID Q8WXI7
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-MUC16, ACA125 Vector (GTVCR-WQ245MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ861MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD52, Campath-1H Vector Vector Campath-1H
GTVCR-WQ1616MR IVTScrip™ pT7-VEE-mRNA-Anti-CD3E&TNFRSF17, JNJ-64007957 Vector Vector JNJ-64007957
GTVCR-WQ542MR IVTScrip™ pSP6-VEE-mRNA-Anti-ANPEP, ARENEGYR Vector Vector ARENEGYR
GTVCR-WQ678MR IVTScrip™ pSP6-VEE-mRNA-Anti-PDCD1, BGB-A317 Vector Vector BGB-A317
GTVCR-WQ1495MR IVTScrip™ pT7-VEE-mRNA-Anti-IL1B, IL-1 Trap Vector Vector IL-1 Trap
GTVCR-WQ2056MR IVTScrip™ pT7-VEE-mRNA-Anti-CD274, MSB-0010718C Vector Vector MSB-0010718C
GTVCR-WQ858MR IVTScrip™ pSP6-VEE-mRNA-Anti-CSF2RA, CAM-3001 Vector Vector CAM-3001
GTVCR-WQ2495MR IVTScrip™ pT7-VEE-mRNA-Anti-stx2 A-subunit, Shigamabs® Vector Vector Shigamabs®
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.